GlaxoSmithKline admits execs breached Chinese law

British drug giant, GlaxoSmithKline admitted that some of its executives in China appear to have violated Chinese law in a bribery and corruption scandal which has hit the firm.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.